CTI BioPharma CEO Adam Craig's 2019 pay falls 44% to $1.7M
CTI BioPharma reports 2019 executive compensation
By ExecPay News
Published: April 23, 2020
CTI BioPharma reported fiscal year 2019 executive compensation information on April 23, 2020.
In 2019, three executives at CTI BioPharma received on average a compensation package of $1.1M, a 29% decrease compared to previous year.
Average pay of disclosed executives at CTI BioPharma
Adam R. Craig, Chief Executive Officer, received $1.7M in total, which decreased by 44% compared to 2018. 41% of Craig's compensation, or $703K, was in option awards. Craig also received $396K in non-equity incentive plan, $595K in salary, as well as $8.4K in other compensation.
Bruce J. Seeley, Chief Operating Officer, received a compensation package of $859K, which decreased by 24% compared to previous year. 49% of the compensation package, or $421K, was in salary.
David H. Kirske, Chief Financial Officer, earned $832K in 2019, a 6% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 23, 2020.